Campaign

Company Summary :

Ostoform has introduced a flexible, non-absorbent technology - FLOWASSIST - secured around the stoma, to effectively drain the corrosive output away from the skin and into the stoma bag, so the skin stays healthy, giving the patient confidence. The products are now on the market in Europe and the US.

Key highlights:

• 93% of ostomy patients worry about leakage
• 60% experience skin complications accounting for one third of all ostomy nurse visits.
• Five peer-reviewed clinical studies have been published demonstrating the effectiveness of FLOWASSIST. Independent reports on healthcare cost savings have resulted in premium reimbursement in the UK and Ireland.
• High-volume production lines of the FLOWASSIST product range are established with manufacturing partners.
• Ostoform’s core product range, the FLOWASSIST Seal and FLOWASSIST Pouch, is now fully developed and ready for commercial scale-up.
• Global ostomy market is worth $3 billion, with serviceable addressable market (SAM) in the US worth $350m.
• Full US market access (reimbursement, regulatory approval and GPO listings) has been established.
• Institutional investors are participating in this €2.1m funding round.
• Ostoform’s products are now supplied by 3 of the largest medical device distributors in the US.